Changzhong Li

2.1k total citations
115 papers, 1.4k citations indexed

About

Changzhong Li is a scholar working on Molecular Biology, Epidemiology and Obstetrics and Gynecology. According to data from OpenAlex, Changzhong Li has authored 115 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 24 papers in Epidemiology and 24 papers in Obstetrics and Gynecology. Recurrent topics in Changzhong Li's work include Cervical Cancer and HPV Research (19 papers), Endometriosis Research and Treatment (18 papers) and Cancer-related molecular mechanisms research (15 papers). Changzhong Li is often cited by papers focused on Cervical Cancer and HPV Research (19 papers), Endometriosis Research and Treatment (18 papers) and Cancer-related molecular mechanisms research (15 papers). Changzhong Li collaborates with scholars based in China, Hong Kong and United States. Changzhong Li's co-authors include Liping Xie, Fang Wang, Yi Liu, Ledan Wang, Qiang Sun, Bo Liu, Ningping Gong, Zhenguang Yan, Rongqing Zhang and Jing Gu and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Changzhong Li

105 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changzhong Li China 22 419 310 226 226 224 115 1.4k
Liqun Wang China 14 197 0.5× 90 0.3× 122 0.5× 98 0.4× 89 0.4× 38 1.1k
Anil K. Sood United States 26 1.1k 2.7× 41 0.1× 244 1.1× 608 2.7× 102 0.5× 142 2.5k
Brendan H. Grubbs United States 26 1.1k 2.7× 68 0.2× 266 1.2× 102 0.5× 406 1.8× 129 2.5k
Yen-Ta Chen Taiwan 24 738 1.8× 50 0.2× 123 0.5× 156 0.7× 22 0.1× 68 1.9k
Yujing Cao China 23 526 1.3× 26 0.1× 242 1.1× 86 0.4× 126 0.6× 68 1.4k
Yoshihiko Shimizu Japan 24 784 1.9× 28 0.1× 100 0.4× 168 0.7× 90 0.4× 175 2.3k
Jiao Chen China 22 745 1.8× 40 0.1× 30 0.1× 280 1.2× 49 0.2× 116 1.7k
Qingxue Zhang China 23 394 0.9× 43 0.1× 714 3.2× 103 0.5× 149 0.7× 66 2.0k
Jianlin Zhang China 27 1.4k 3.3× 97 0.3× 16 0.1× 326 1.4× 41 0.2× 113 2.6k
Qin Yao China 20 564 1.3× 38 0.1× 27 0.1× 366 1.6× 37 0.2× 74 1.5k

Countries citing papers authored by Changzhong Li

Since Specialization
Citations

This map shows the geographic impact of Changzhong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changzhong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changzhong Li more than expected).

Fields of papers citing papers by Changzhong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changzhong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changzhong Li. The network helps show where Changzhong Li may publish in the future.

Co-authorship network of co-authors of Changzhong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Changzhong Li. A scholar is included among the top collaborators of Changzhong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changzhong Li. Changzhong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Du, Hui, Wenkui Dai, Di Wu, et al.. (2025). Expanding access to cervical cancer screening: The performance of self-sampled urine HPV testing. International Journal of Infectious Diseases. 161. 108175–108175.
3.
Liu, Kan, Qili Sun, Ying‐Tong Di, et al.. (2025). HEP14 treatment improves ovarian function in aged mice through mitophagy enhancement and oxidative stress reduction. Communications Biology. 8(1). 1141–1141. 2 indexed citations
4.
Liu, Yu, Changzhong Li, Zhihong Liu, et al.. (2024). Photodynamic therapy compared with loop electrosurgical excision procedure in patients with cervical high-grade squamous intraepithelial lesion. Scientific Reports. 14(1). 27090–27090. 3 indexed citations
5.
Liu, Wei, et al.. (2024). Uterine arteriovenous malformation: a case report with proposal for pathogenesis. BMC Women s Health. 24(1). 541–541.
6.
Liu, Yu, et al.. (2024). Hiporfin photodynamic therapy for early-stage cervical cancer: A case report. Photodiagnosis and Photodynamic Therapy. 50. 104422–104422.
7.
Liu, Yu, et al.. (2024). Photodynamic therapy with HiPorfin for cervical squamous intraepithelial lesion at childbearing age. Photodiagnosis and Photodynamic Therapy. 46. 104018–104018. 4 indexed citations
8.
Liu, Yu, et al.. (2024). Successful pregnancy and delivery after HiPorfin photodynamic therapy for cervical high-grade squamous intraepithelial lesion. Photodiagnosis and Photodynamic Therapy. 46. 104062–104062. 5 indexed citations
9.
Huang, Di, Jing Liu, Jie Yang, et al.. (2024). Restoration of Pregnancy Function Using a GT/PCL Biofilm in a Rabbit Model of Uterine Injury. Tissue Engineering Part A. 31(1-2). 29–44.
10.
Du, Hui, Wenkui Dai, Qian Zhou, et al.. (2023). AI-assisted system improves the work efficiency of cytologists via excluding cytology-negative slides and accelerating the slide interpretation. Frontiers in Oncology. 13. 1290112–1290112. 5 indexed citations
11.
Wang, Yinan, Hui Du, Wenkui Dai, et al.. (2023). Diagnostic Potential of Endometrial Cancer DNA from Pipelle, Pap-Brush, and Swab Sampling. Cancers. 15(13). 3522–3522. 3 indexed citations
12.
Wu, Xiangchen, Changzhong Li, Haoyuan Chen, et al.. (2023). CAM-VT: A Weakly supervised cervical cancer nest image identification approach using conjugated attention mechanism and visual transformer. Computers in Biology and Medicine. 162. 107070–107070. 38 indexed citations
13.
14.
Zhang, Yulong, Changzhong Li, Wenhui Zhang, Xiangqin Zheng, & Xiujuan Chen. (2020). Decreased Insulin Resistance by Myo-Inositol Is Associated with Suppressed Interleukin 6/Phospho-STAT3 Signaling in a Rat Polycystic Ovary Syndrome Model. Journal of Medicinal Food. 23(4). 375–387. 23 indexed citations
15.
Liu, Zhitong, Bo Liu, & Changzhong Li. (2019). A case report of metastatic bilateral ovarian cancer due to non-small cell lung cancer with ALK gene rearrangement. European Journal of Gynaecological Oncology. 40(1). 151–153. 2 indexed citations
16.
Shi, Min, Hui Zhang, Ming Liu, et al.. (2018). MicroRNA-200 and microRNA-30 family as prognostic molecular signatures in ovarian cancer. Medicine. 97(32). e11505–e11505. 29 indexed citations
17.
Wan, Jipeng, Lei Li, Fei Wang, et al.. (2016). Role of UMOD Promoter Polymorphism in the Etiology of Preeclampsia. Genetic Testing and Molecular Biomarkers. 20(8). 471–474. 1 indexed citations
18.
Li, Mingjiang, Hui Zhang, Xingbo Ζhao, et al.. (2014). SPRY4-mediated ERK1/2 signaling inhibition abolishes 17β-estradiol-induced cell growth in endometrial adenocarcinoma cell. Gynecological Endocrinology. 30(8). 600–604. 6 indexed citations
19.
Wan, Jipeng, et al.. (2013). The Common Variant rs11646213 Is Associated with Preeclampsia in Han Chinese Women. PLoS ONE. 8(8). e71202–e71202. 11 indexed citations
20.
Zhang, Chunhua, Jianfeng Li, Changzhong Li, et al.. (2008). Inhibition of proliferation and transforming growth factor β3 protein expression by peroxisome proliferators-activated receptor γ ligands in human uterine leiomyoma cells. Chinese Medical Journal. 121(2). 166–171. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liqun Wang Breakdown of academic impact, for papers by Anil K. Sood Breakdown of academic impact, for papers by Brendan H. Grubbs Breakdown of academic impact, for papers by Yen-Ta Chen Breakdown of academic impact, for papers by Yujing Cao Breakdown of academic impact, for papers by Yoshihiko Shimizu Breakdown of academic impact, for papers by Jiao Chen Breakdown of academic impact, for papers by Qingxue Zhang Breakdown of academic impact, for papers by Jianlin Zhang Breakdown of academic impact, for papers by Qin Yao
Rankless by CCL
2026